EOLS
Evolus Inc
NASDAQ: EOLS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.18
-1.71% today
Updated 2026-04-29
Market cap
$344.82M
P/E ratio
—
P/S ratio
1.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$4 – $12
Volume
1.1M
Evolus Inc (EOLS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-17.40%
Operating margin
-0.32%
ROE
-18,730.00%
ROA
-10.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-31.11M | — | — | — |
| 2016 | $0.00 | $-20.07M | — | — | — |
| 2017 | $0.00 | $-4.48M | — | — | — |
| 2018 | $0.00 | $-46.87M | — | — | — |
| 2019 | $34.92M | $-90.03M | 77.05% | -283.31% | -257.79% |
| 2020 | $56.54M | $-163.01M | 67.64% | -270.73% | -288.31% |
| 2021 | $99.67M | $-46.81M | 56.32% | -44.55% | -46.96% |
| 2022 | $148.62M | $-74.41M | 60.41% | -43.96% | -50.07% |
| 2023 | $202.09M | $-61.69M | 69.54% | -24.36% | -30.52% |
| 2024 | $266.27M | $-50.42M | 68.46% | -12.92% | -18.94% |
| 2025 | $297.18M | $-51.64M | 64.86% | -12.65% | -17.38% |